Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Xingnao Granules
- Development stage
- Unknown
- Lead developer
- Beijing Hengqingtang Pharmaceutical Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shenqi Xingnao Granules is a Traditional Chinese Medicine (TCM) botanical formulation developed by Beijing Hengqingtang Medical Technology for the treatment of mild Alzheimer's disease. The drug is designed to address cognitive decline through the traditional principles of tonifying Qi and 'awakening the brain.' It is currently undergoing Phase II clinical trials in China to evaluate its efficacy and safety in patients with mild Alzheimer's disease. As a TCM product, it likely contains multiple herbal extracts, typically including Ginseng and Astragalus, which are traditionally used to support cognitive function and overall vitality.
- Brand names
- Shenqi Xingnao Granules
- Other names
- 参芪醒脑颗粒Shenqi Xingnao Keli
02
Targets
GSK3 (Glycogen synthase kinase 3 beta)BACE1 (Beta-site APP-cleaving enzyme 1)IDE (Insulin-degrading enzyme)AcetylcholinesteraseAβ (Amyloid-beta peptides and aggregates)
Beyond the preview
Go deeper on Shenqi Xingnao Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenqi Xingnao Granules.